- Home
- IMAB vs PUBM Comparison
IMAB vs PUBM Comparison
Compare IMAB & PUBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAB
- PUBM
- Stock Information
- Founded
- IMAB 2014
- PUBM 2006
- Country
- IMAB United States
- PUBM United States
- Employees
- IMAB N/A
- PUBM N/A
- Industry
- IMAB Biotechnology: Pharmaceutical Preparations
- PUBM Computer Software: Prepackaged Software
- Sector
- IMAB Health Care
- PUBM Technology
- Exchange
- IMAB Nasdaq
- PUBM Nasdaq
- Market Cap
- IMAB 394.2M
- PUBM 382.7M
- IPO Year
- IMAB 2020
- PUBM 2020
- Fundamental
- Price
- IMAB $4.39
- PUBM $8.26
- Analyst Decision
- IMAB Strong Buy
- PUBM Buy
- Analyst Count
- IMAB 6
- PUBM 11
- Target Price
- IMAB $7.17
- PUBM $18.05
- AVG Volume (30 Days)
- IMAB 1.7M
- PUBM 569.1K
- Earning Date
- IMAB 11-02-2025
- PUBM 11-11-2025
- Dividend Yield
- IMAB N/A
- PUBM N/A
- EPS Growth
- IMAB N/A
- PUBM N/A
- EPS
- IMAB N/A
- PUBM N/A
- Revenue
- IMAB N/A
- PUBM $292,208,000.00
- Revenue This Year
- IMAB N/A
- PUBM N/A
- Revenue Next Year
- IMAB N/A
- PUBM $1.40
- P/E Ratio
- IMAB N/A
- PUBM N/A
- Revenue Growth
- IMAB N/A
- PUBM 3.53
- 52 Week Low
- IMAB $0.60
- PUBM $7.01
- 52 Week High
- IMAB $5.90
- PUBM $17.74
- Technical
- Relative Strength Index (RSI)
- IMAB 59.97
- PUBM 44.09
- Support Level
- IMAB $3.98
- PUBM $8.19
- Resistance Level
- IMAB $4.51
- PUBM $8.58
- Average True Range (ATR)
- IMAB 0.30
- PUBM 0.30
- MACD
- IMAB 0.07
- PUBM 0.05
- Stochastic Oscillator
- IMAB 89.30
- PUBM 22.73
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).
About PUBM PubMatic Inc.
PubMatic Inc is a supply-side platform provider in the digital advertising technology market. These platforms help publishers, which supply digital ad inventory, manage their inventory, selling a high percentage of their inventory (increase the ad fill rate) and maximizing revenue per ad sold (optimize yield). The company generates revenue mainly by taking a piece of the ad sales that it enables. Buyers on the platform include intermediary buyers, such as demand-side platforms, or advertisers and ad agencies directly. Geographically, the company generates the majority of its revenue from the United States, followed by EMEA and APAC.